MedTrace Logo

The Supplementary Effects of the Extract of Agaricus Blazei Murril on Type II Diabetes Mellitus (DM)

NCT00131287 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2010-01-05

No results posted yet for this study

Summary

The purpose of this study is to examine whether the extract of the Agaricus blazei Murill mushroom is effective in the supplementary treatment of type II DM patients.

Conditions

  • Diabetes Mellitus, Type II

Interventions

DRUG

Extract of Agaricus blazei Murill

Sponsors & Collaborators

  • ECbiotech Taiwan

    lead OTHER

Principal Investigators

  • Hsu Chung-Hua, MD · Chinese Medicine Dep, Taipei Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-07-31
Completion
2006-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00131287 on ClinicalTrials.gov